Targeted killing of carcinoembryonic antigen (CEA)-producing cholangiocarcinoma cells by polyamidoamine dendrimer-mediated transfer of an Epstein-Barr virus (EBV)-based plasmid vector carrying the CEA promoter

Abstract

The present study reports a novel nonviral method to efficiently and specifically target carcinoembryonic antigen (CEA)-producing cholangiocarcinoma (CC) cells in vitro. Epstein-Barr virus (EBV)-based and conventional plasmid vectors were constructed that possess the β-galactosidase (β-gal) or herpes simplex virus-1 (HSV-1) thymidine kinase (Tk) genes as well as tandem repeats of the human genomic sequence −82 to −42 bp from the transcriptional start site of the CEA gene. The plasmids were transfected by means of polyamidoamine dendrimer into CEA-positive (HuCC-T1) or -negative cell lines. Transfection of the conventional plasmid vector with the CEA promoter and β-gal gene resulted in a very low or undetectable level of marker gene expression even in the CEA-positive cell line. Transferring the HSV-1 Tk gene by conventional plasmid did not affect the susceptibility of HuCC-T1 cells to ganciclovir. In marked contrast, strong β-gal expression was specifically obtained in HuCC-T1 cells by transfecting the EBV-based plasmid in which the CEA promoter and a ubiquitous promoter (SRα) are employed to drive the EBV-encoded nuclear antigen 1 (EBNA1) and β-gal genes, respectively (pTES.β). Furthermore, CEA-positive but not -negative tumor cells were rendered highly susceptible to ganciclovir when transfected with the EBV-based vector that carries the CEA promoter-EBNA1 and SRα-HSV-1 Tk genes (pTES.Tk). These results strongly suggest that the EBV-based plasmid vector/cationic polymer system (EBV/polyplex) equipped with the CEA promoter provides an efficient nonviral method for the targeted gene therapy of CEA-producing malignancies.

DOI: 10.1038/sj.cgt.7700219

Statistics

0200400'02'04'06'08'10'12'14'16
Citations per Year

684 Citations

Semantic Scholar estimates that this publication has 684 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Tanaka2000TargetedKO, title={Targeted killing of carcinoembryonic antigen (CEA)-producing cholangiocarcinoma cells by polyamidoamine dendrimer-mediated transfer of an Epstein-Barr virus (EBV)-based plasmid vector carrying the CEA promoter}, author={Saiyu Tanaka and Masaki Iwai and Yoshinori Harada and Teruhisa Morikawa and Akira Muramatsu and Takahiro Mori and Takeshi Okanoue and Kei Kashima and Hiroko Maruyama-Tabata and Hideyo Hirai and Etsuko Satoh and Jiro Imanishi and Osam Mazda}, journal={Cancer Gene Therapy}, year={2000}, volume={7}, pages={1241-1249} }